Beranda1PG • FRA
add
Aker Biomarine ASA
Tutup sebelumnya
€5,56
Rentang hari
€5,63 - €5,63
Rentang tahun
€3,80 - €8,91
Volume Rata-Rata
39,00
Rasio P/E
-
Hasil dividen
-
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 50,80 jt | 4,74% |
Biaya operasional | 20,20 jt | -11,79% |
Laba bersih | -3,10 jt | 73,95% |
Margin laba bersih | -6,10 | 75,14% |
Penghasilan per saham | — | — |
EBITDA | 4,10 jt | -57,73% |
Tarif pajak efektif | -42,86% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 16,00 jt | -50,00% |
Total aset | 389,60 jt | -52,11% |
Total liabilitas | 219,00 jt | -52,27% |
Total ekuitas | 170,60 jt | — |
Saham yang beredar | 87,69 jt | — |
Harga terhadap nilai buku | 2,85 | — |
Tingkat pengembalian aset | -0,13% | — |
Tingkat pengembalian modal | -0,15% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -3,10 jt | 73,95% |
Kas dari operasi | -10,90 jt | -626,67% |
Kas dari investasi | -2,60 jt | 43,48% |
Kas dari pembiayaan | 14,50 jt | 38,10% |
Perubahan kas bersih | 1,00 jt | -77,27% |
Arus kas bebas | -11,14 jt | -474,37% |
Tentang
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION and Understory. Aker BioMarine is listed on the Oslo Stock Exchange. Wikipedia
Didirikan
2006
Situs
Karyawan
249
